Byler's disease
Byler's Disease Byler's Disease, also known as Progressive Familial Intrahepatic Cholestasis (PFIC), is a rare genetic disorder that affects the liver's ability to secrete bile. This condition leads to the accumulation of bile acids in the liver, causing liver damage and a variety of symptoms.
Etiology[edit | edit source]
Byler's Disease is caused by mutations in genes responsible for bile transport. The most common genes involved are ]]ATP8B1]], ]]ABCB11]], and ]]ABCB4]]. These genes encode proteins that are crucial for the proper functioning of bile transport mechanisms in liver cells.
Pathophysiology[edit | edit source]
The mutations in these genes lead to impaired bile flow from the liver to the gallbladder and intestine. This results in the accumulation of bile acids in the liver, causing liver cell damage and inflammation. Over time, this can lead to liver fibrosis and cirrhosis.
Clinical Presentation[edit | edit source]
Patients with Byler's Disease typically present in infancy or early childhood with symptoms such as:
- Severe itching (pruritus)
- Jaundice
- Failure to thrive
- Hepatomegaly (enlarged liver)
Diagnosis[edit | edit source]
Diagnosis of Byler's Disease involves a combination of clinical evaluation, laboratory tests, and genetic testing. Liver function tests often show elevated levels of bile acids, bilirubin, and liver enzymes. Genetic testing can confirm mutations in the associated genes.
Treatment[edit | edit source]
There is no cure for Byler's Disease, but treatment focuses on managing symptoms and preventing complications. Treatment options include:
- Ursodeoxycholic acid to improve bile flow
- Rifampicin to reduce itching
- Liver transplantation in severe cases
Prognosis[edit | edit source]
The prognosis for individuals with Byler's Disease varies depending on the severity of the condition and the effectiveness of treatment. Early diagnosis and management can improve outcomes, but many patients may eventually require liver transplantation.
Research and Future Directions[edit | edit source]
Ongoing research is focused on understanding the genetic basis of Byler's Disease and developing targeted therapies. Gene therapy and novel pharmacological agents are areas of active investigation.
See Also[edit | edit source]
NIH genetic and rare disease info[edit source]
Byler's disease is a rare disease.
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD
